Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

August 16, 2022

Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD

Autosomal dominant polycystic kidney disease (ADPKD) is a major genetic disorder affecting up to 12 million individuals worldwide

Four PKD Reports Published in CJASN

C-Path and PKDOC are excited to announce that four reports summarizing Sessions 1, 2, and 3B from the 2021 PKD Regulatory Summit h

Upcoming Rare Disease Workshop Focuses on the Importance of Data Sharing in Drug Development

C-Path, NORD and FDA to host annual workshop September 13-14 to highlight the impact of their innovative data and analytics platfo

Oak Hill Bio Joins C-Path’s International Neonatal Consortium

TUCSON, Ariz., Aug. 24, 2022 — Critical Path Institute (C-Path) today announced that Oak Hill Bio (Oak Hill), a clinical-stage n

August 16, 2022

Obtaining and Using TPOXX (Tecovirimat) for the Treatment of Monkeypox

September 22, 2022

View Now: Workshop: Accelerating Medical Product Development in Kidney Transplantation Through a Public-private Partnership

C-Path’s Transplant Therapeutics Consortium (TTC), in collaboration with key opinion leaders from academic institutions, the pha

August 12, 2022

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

C-Path’s Type 1 Diabetes Consortium (T1DC) is pleased to announce that “Consortium-based approach to receiving an EMA...

October 13, 2022-October 14, 2022

DIA 2022 Digital Technology in Clinical Trials Conference

Early bird rates in effect until August 18! C-Path’s eCOA Consortium is co-sponsoring the DIA 2022 Digital Technology in Clini

August 17, 2022

View Now | Addressing the Gaps in Clinical Trial Readiness for FSHD

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common myopathies affecting anywhere between 1:8,000 to 1:20,000

September 13, 2022-September 14, 2022

View Now | 2022 RDCA-DAP Workshop, September 13-14

Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i

Previous4041 42...124 Next